Autoimmune Disease Diagnostics Market Size, Share Detailed Report 2026 to 2035
Market Segmentation:
Autoimmune Disease Diagnostics Market by Product-
- Instruments
- Consumables and Assays
Autoimmune Disease Diagnostics Market by Test-
- C-reactive Protein (CRP)
- Antinuclear antibody tests
- Complete blood count (CBC)
- Urinalysis
- Autoantibody tests
- Others
Autoimmune Disease Diagnostics Market by Type-
- Localized autoimmune disease diagnostics
-
- Type 1 diabetes
- Multiple sclerosis
- Hashimoto's Thyroiditis
- Idiopathic thrombocytopenic purpura
- Others
- Systemic autoimmune disease diagnostics
-
- Ankylosing spondylitis
- Rheumatoid arthritis
- Systemic lupus erythematosus (SLE)
- Others
Autoimmune Disease Diagnostics Market by End-user-
- Hospitals
- Diagnostic centers
- Others
By Region-
North America-
- The US
- Canada
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Autoimmune Disease Diagnostics Market Snapshot
Chapter 4. Global Autoimmune Disease Diagnostics Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Porter’s Five Forces Analysis
4.7. Incremental Opportunity Analysis (US$ Mn), 2026–2035
4.8. Global Autoimmune Disease Diagnostics Market Penetration & Growth Prospect Mapping (US$ Mn), 2025–2035
4.9. Competitive Landscape & Market Share Analysis, By Key Player (2025)
4.10. Use/Impact of AI on Autoimmune Disease Diagnostics Industry Trends
Chapter 5. Autoimmune Disease Diagnostics Market Segmentation 1: By Product, Estimates & Trend Analysis
5.1. Market Share by Product, 2025 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022–2035 for the following Product:
5.2.1. Instruments
5.2.2. Consumables and Assays
Chapter 6. Autoimmune Disease Diagnostics Market Segmentation 2: By Test, Estimates & Trend Analysis
6.1. Market Share by Test, 2025 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022–2035 for the following Test:
6.2.1. C-Reactive Protein (CRP)
6.2.2. Antinuclear Antibody Tests
6.2.3. Complete Blood Count (CBC)
6.2.4. Urinalysis
6.2.5. Autoantibody Tests
6.2.6. Others
Chapter 7. Autoimmune Disease Diagnostics Market Segmentation 3: By Type, Estimates & Trend Analysis
7.1. Market Share by Type, 2025 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022–2035 for the following Type:
7.2.1. Localized Autoimmune Disease Diagnostics
7.2.1.1. Type 1 Diabetes
7.2.1.2. Multiple Sclerosis
7.2.1.3. Hashimoto’s Thyroiditis
7.2.1.4. Idiopathic Thrombocytopenic Purpura
7.2.1.5. Others
7.2.2. Systemic Autoimmune Disease Diagnostics
7.2.2.1. Ankylosing Spondylitis
7.2.2.2. Rheumatoid Arthritis
7.2.2.3. Systemic Lupus Erythematosus (SLE)
7.2.2.4. Others
Chapter 8. Autoimmune Disease Diagnostics Market Segmentation 4: By End-User, Estimates & Trend Analysis
8.1. Market Share by End-User, 2025 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022–2035 for the following End-User:
8.2.1. Hospitals
8.2.2. Diagnostic Centers
8.2.3. Others
Chapter 9. Autoimmune Disease Diagnostics Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. Global Autoimmune Disease Diagnostics Market Regional Snapshot, 2025 & 2035
9.2. North America
9.2.1. North America Market Revenue (US$ Mn) Estimates and Forecasts by Country, 2022–2035
9.2.1.1. United States
9.2.1.2. Canada
9.2.2. North America Market Revenue Estimates by Product, 2022–2035
9.2.3. North America Market Revenue Estimates by Test, 2022–2035
9.2.4. North America Market Revenue Estimates by Type, 2022–2035
9.2.5. North America Market Revenue Estimates by End-User, 2022–2035
9.2.6. North America Market Analysis
9.3. Europe
9.3.1. Europe Market Revenue Estimates and Forecasts by Country, 2022–2035
9.3.1.1. Germany
9.3.1.2. United Kingdom
9.3.1.3. France
9.3.1.4. Italy
9.3.1.5. Spain
9.3.1.6. Rest of Europe
9.3.2. Europe Market Revenue Estimates by Product, 2022–2035
9.3.3. Europe Market Revenue Estimates by Test, 2022–2035
9.3.4. Europe Market Revenue Estimates by Type, 2022–2035
9.3.5. Europe Market Revenue Estimates by End-User, 2022–2035
9.3.6. Europe Market Analysis
9.4. Asia Pacific
9.4.1. Asia Pacific Market Revenue Estimates and Forecasts by Country, 2022–2035
9.4.1.1. China
9.4.1.2. Japan
9.4.1.3. India
9.4.1.4. South Korea
9.4.1.5. South East Asia
9.4.1.6. Rest of Asia Pacific
9.4.2. Asia Pacific Market Revenue Estimates by Product, 2022–2035
9.4.3. Asia Pacific Market Revenue Estimates by Test, 2022–2035
9.4.4. Asia Pacific Market Revenue Estimates by Type, 2022–2035
9.4.5. Asia Pacific Market Revenue Estimates by End-User, 2022–2035
9.4.6. Asia Pacific Market Analysis
9.5. Latin America
9.5.1. Latin America Market Revenue Estimates by Country, 2022–2035
9.5.1.1. Brazil
9.5.1.2. Argentina
9.5.1.3. Mexico
9.5.1.4. Rest of Latin America
9.5.2. Latin America Market Revenue Estimates by Product, 2022–2035
9.5.3. Latin America Market Revenue Estimates by Test, 2022–2035
9.5.4. Latin America Market Revenue Estimates by End-User, 2022–2035
9.5.5. Latin America Market Analysis
9.6. Middle East & Africa
9.6.1. Middle East & Africa Market Revenue Estimates by Country, 2022–2035
9.6.1.1. GCC Countries
9.6.1.2. South Africa
9.6.1.3. Rest of Middle East & Africa
9.6.2. Middle East & Africa Market Revenue Estimates by Product, 2022–2035
9.6.3. Middle East & Africa Market Revenue Estimates by Test, 2022–2035
9.6.4. Middle East & Africa Market Revenue Estimates by End-User, 2022–2035
9.6.5. Middle East & Africa Market Analysis
Chapter 10. Competitive Landscape
10.1. Major Mergers, Acquisitions & Strategic Alliances
10.2. Company Profiles
10.2.1. Hoffmann-La Roche Ltd
10.2.2. Abbott
10.2.3. Siemens Healthineers AG
10.2.4. Quest Diagnostics
10.2.5. Nova Diagnostics Pte Ltd.
10.2.6. Beckman Coulter, Inc.
10.2.7. Danaher Corporation
10.2.8. BIOMÉRIEUX
10.2.9. Hemagen Diagnostics, Inc.
10.2.10. EUROIMMUN Medizinische Labordiagnostika AG
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Autoimmune Disease Diagnostics Market Size is valued at USD 6.41 Bn in 2025 and is predicted to reach USD 11.63 Bn by the year 2035
Autoimmune Disease Diagnostics Market Size is predicted to develop at a 6.0% CAGR during the forecast period for 2026 to 2035.
F. Hoffmann-La Roche Ltd, Abbott, Siemens Healthineers AG, Quest Diagnostics, Nova Diagnostics Pte Ltd., Beckman Coulter, Inc., Danaher Corporation, BIOMÉRIEUX, Hemagen Diagnostics, Inc., and EUROIMMUN Medizinische Labordiagnostika AG
Autoimmune Disease Diagnostics Market is segmented into Product, Test, Type, End-user, and By Region.
North America region is leading the Autoimmune Disease Diagnostics Market.